Letrazole(Femara)
Keywords:Letrozole,FEMARA,LETROZOL,LETRAZOLE,Lelrozol , 112809-51-5, letrozolex
Product name: Letrozole
CAS: 112809-51-5
MF: C17H11N5
MW: 285.3
Description: Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
skype:Zhai Vivien email:yml11@yccreate.com
Wuhan Yuancheng Gongchuang Technology Co.Ltd.is a comprehensive and high-tech enterprise special in Plant Extracts, Integrating R&D, Manufacturing, Operating and Marketing into an organic whole. The company is located in Xiaogan city, nearby national highways of No.107, marched with Wuhan city.
Our factory covers an area of 33500 square meters, with clean environment and nice layout. There are several large-sized, medium-sized workshops and QA and research center with advanced equipments.
...
View more >>
Basic Information
Business Type: Manufacturer,Agent,Distributor/Wholesaler
Product/Service (We Buy): 501 - 1000 People
Ownership Type: Individual (Sole proprietorship)
Registered Capital: US$2.5 Million - US$5 Million
Year Established: 2001
Number of Employees: 501 - 1000 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
QA/QC: In House
Number of Production Lines: 1
Number of R&D Staff: 103
Number of QC Staff: 91 - 100 People
Total Annual Sales Volume: US$10 Million - US$50 Million
China
